Last update 01 Nov 2024

Celgene Europe BV

Subsidiary Company|
Netherlands

Overview

Related

1
Drugs associated with Celgene Europe BV
Azacitidine
Target
DNMT1
Mechanism
DNMT1 inhibitors [+1]
Active Org.
betapharm Arzneimittel GmbHbetapharm Arzneimittel GmbH [+21]
Originator Org.
Celgene Corp.Celgene Corp.
Active Indication
Juvenile Myelomonocytic Leukemia [+50]
Inactive Indication
Acute myeloid leukaemia with 11q23 abnormality [+57]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date19 May 2004
100 Clinical Results associated with Celgene Europe BV
Login to view more data
0 Patents (Medical) associated with Celgene Europe BV
Login to view more data
100 Deals associated with Celgene Europe BV
Login to view more data
100 Translational Medicine associated with Celgene Europe BV
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 17 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Azacitidine
 ( DNMT1 )		Myelodysplastic Syndromes
More
Withdrawn
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free